Bio Sequence

Finding the Complete Antibody Sequence Using a Known CDR Sequence: An Exploration with Patsnap Bio Sequence Database

18 October 2023
2 min read

One can elucidate the entire antibody sequence by utilizing a known Complementarity-determining region (CDR) sequence in combination with the accessible Patsnap Bio Sequence Database. This resource is complimentary and requires only a simple registration process.

 

To embark on this journey, access the Bio database account registration here. Upon entering the vibrant interface of the database homepage, look for the antibody search option and input the desired CDR sequence into the search field (Refer to Figure 1 for visual guidance).

图形用户界面, 应用程序, Word

描述已自动生成

Activating the search button will transport you to the search results page (Outlined in Figure 2). In this arena, you can peruse the number of sequences hit, and review their availability in the public domain. By engaging with the numerical values below the sequence, the gateway to a deep understanding of the hit sequences is unlocked. 

图形用户界面, 应用程序, Teams

描述已自动生成

Sifting through the multitude of antibodies will lead to the discovery of the comprehensive hit antibody sequences (Graphically represented in Figure 3). With the foundation of the hit sequences, one can delve further into analysis by examining related patent information. This process could provide valuable insights and enhance the depth of your exploration.

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

It is important to note that Patsnap Bio is the most extensive sequence search platform for the Patsnap database. It incorporates AI with human-curated data for comprehensive handling of protein and nucleotide sequence data plucked from global patents, biological periodicals, and public repositories. Essential biological sequences are manually annotated, illuminating structural modifications to provide the most accurate sequence data and boost sequence retrieval efficiency.

Free registration is available for the Bio biological sequence database: https://bio.patsnap.com. Act now to expedite your sequence search tasks.

Latest Competitive Analysis of Merck Sharp & Dohme Drug Pipeline
R&D Pipeline
2 min read
Latest Competitive Analysis of Merck Sharp & Dohme Drug Pipeline
18 October 2023
Merck's recent revenue performance remains steady, with the K drug continuing to grow and earning the title of "New Generation Drug King".
Read →
Avidity Biosciences presents encouraging results for AOC 1001, showing progress and long-term safety in multiple areas for Type 1 Myotonic Dystrophy patients
Latest Hotspot
4 min read
Avidity Biosciences presents encouraging results for AOC 1001, showing progress and long-term safety in multiple areas for Type 1 Myotonic Dystrophy patients
18 October 2023
Avidity Biosciences Reports Fresh Positive Results for AOC 1001, Showing Progress in Various Additional Functional Measures and Long-term Safety and Acceptability in Individuals with Type 1 Myotonic Dystrophy.
Read →
Reducing the Risk of FTO Missed Detection in Special Referential Sequences of Patents
Bio Sequence
2 min read
Reducing the Risk of FTO Missed Detection in Special Referential Sequences of Patents
18 October 2023
The patent and literature contain sequences of nucleic acids containing N and protein sequences containing X. I'm interested in reducing the risk of missing such sequences. Is there a recommended database where I can search for these sequences?
Read →
Unveiling the FTO Retrieval of Multi-gene Elements within the AAV Domain
Bio Sequence
2 min read
Unveiling the FTO Retrieval of Multi-gene Elements within the AAV Domain
18 October 2023
In the AAV field, common inventions involve the replacement and combination of expression-related gene regulatory elements.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.